Figure 6From: The effects of telbivudine in late pregnancy to prevent intrauterine transmission of the hepatitis B virus: a systematic review and meta-analysisForest plots of telbivudine vs. control on infant HBV DNA seropositivity at age 6–12 months. A. Pooled effect from the combination of RCTs and NRCTs. B. Pooled effect from NRCTs.Back to article page